Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Drugs in Context|February 10, 2017
Elemental calcium intake associated with calcium acetate/calcium carbonate in the treatment of hyperphosphatemiaRosamund J Wilson, J Brian Copley
SAGE Open Medicine|July 18, 2018
Iron parameters in patients with end-stage renal disease receiving lanthanum carbonate or other non-iron-based phosphate binders: Results from a phase 3, randomized open-label studyRosamund J Wilson, Beverly Jones, Claudio Marelli
Advances in Therapy|December 6, 2013
The real-world dose-relativity of sevelamer hydrochloride and lanthanum carbonate monotherapy in patients with end-stage renal diseaseRosamund J Wilson, Michael S Keith, Peter Preston, et al.
Clinical Therapeutics|July 30, 2014
Cost-minimization analysis of lanthanum carbonate versus sevelamer hydrochloride in US patients with end-stage renal diseaseMichael S Keith, Rosamund J Wilson, Peter Preston, et al.
Nephrology (Carlton, Vic.)|August 2, 2016
Lanthanum carbonate: safety data after 10 yearsAlastair J Hutchison, Rosamund J Wilson, Svetlana Garafola, et al.
BMC Nephrology|February 20, 2013
Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patientsAlastair J Hutchison, Maggie Gill, J Brian Copley, et al.
Clinical Therapeutics|August 24, 2014
Real-world dose-relativity, tablet burden, and cost comparison of conversion between sevelamer hydrochloride/carbonate and lanthanum carbonate monotherapiesMichael S Keith, Scott Sibbel, J Brian Copley, et al.
Plos One|September 3, 2016
Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension StudyNathalie M Goemans, Már Tulinius, Marleen van den Hauwe, et al.
JAMA|April 3, 2022
Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) LevelsSteven E Nissen, Kathy Wolski, Craig Balog, et al.
Pageof 1